4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000020
President and CEO sold 2,000 shares at an average $14.72 ($29,435)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X04/wf-form4_168012433661989.xml…